tirzepatide and glp 1 Results of cardiovascular outcomes trials comparing GLP-1 receptor Cardiovascular outcome studies with GLP-1

One of the challenges of managing DM has been the lack of sufficient evidence for approving the safety and efficacy of SGLT-2is and GLP-1RAs combination therapy, as mentioned by the ESC guidelines as a knowledge gap [13]

However, to the authors knowledge, there are no ongoing, withdrawn or completed clinical trials investigating the potential benefits of acetylcarnitine supplementation in people with long COVID syndrome

doi: 10.3389/fnagi.2025.1617106 Received 23 April 2025 Accepted 30 June 2025 Published 18 September 2025 Volume 17 - 2025 Edited by Francisco Navarrete, Miguel Hernndez University of Elche, Spain Reviewed by Robert Fekete, New York Medical College, United States Yutaka Oji, Juntendo University, Japan Updates Copyright 2025 Chaudhary, Chaudhary and Rawat

Deep Detoxification: Eliminate harmful toxins to revitalize your skin and promote a healthier appearance

LF, Y-QH, and YW: acquisition of data and critical revision of the manuscript for important intellectual content

Our data indicates that additional experimental and clinical studies are necessary to explore the potential application of NPW for the enhancement of chronic gastric ulcer healing